TELMICHEK AH TAB 10.S

About

TELMICHEK AH TAB is a triple-combination antihypertensive medication containing telmisartan, an angiotensin II receptor blocker (ARB); amlodipine, a dihydropyridine calcium channel blocker (CCB); and hydrochlorothiazide, a thiazide diuretic. This powerful combination is indicated for the treatment of essential hypertension, particularly in patients whose blood pressure is not adequately controlled by dual therapy. Telmisartan relaxes blood vessels, amlodipine dilates them and reduces peripheral resistance, while hydrochlorothiazide promotes the excretion of excess sodium and water. By targeting multiple pathways involved in blood pressure regulation, this medication provides comprehensive and robust blood pressure control, significantly reducing the risk of cardiovascular events in patients with resistant hypertension.

Uses

• Treatment of essential hypertension, especially resistant hypertension.
• For patients requiring multiple agents for blood pressure control.
• Reduction of cardiovascular risk in high-risk hypertensive patients.
• Management of hypertension with associated fluid retention.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Provides superior blood pressure control through triple action.
• Effectively manages resistant hypertension.
• Significantly reduces the risk of major cardiovascular events.
• Offers the convenience of a single daily tablet for complex regimens.
• Targets multiple mechanisms of hypertension.
• May improve patient adherence compared to taking multiple pills.

Side Effects

• Dizziness
• Headache
• Peripheral edema (swelling of ankles/feet)
• Fatigue
• Nausea
• Diarrhea
• Hypotension
• Palpitations
• Muscle cramps
• Electrolyte imbalances (e.g., hypokalemia)
• Increased uric acid
• Cough

Safety Measures

• Alcohol - Alcohol can significantly enhance the blood pressure-lowering effects of this combination, leading to severe dizziness or fainting. Avoid or limit alcohol.
• Pregnancy - Contraindicated during the second and third trimesters of pregnancy due to the risk of serious fetal injury or death. Avoid use.
• Breastfeeding - All active components are excreted in breast milk. Breastfeeding is not recommended while taking this medication.
• Liver - Use with extreme caution in patients with severe hepatic impairment or biliary obstructive disorders, as it may worsen liver function or precipitate hepatic coma.
• Kidney - Contraindicated in patients with anuria or severe renal impairment. Careful monitoring and dose adjustments are crucial for moderate impairment.
• Lung - Generally safe for use in patients with lung conditions, but caution is advised in those with a history of allergy to sulfonamide-derived drugs (due to HCTZ component).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.